funding
It is currently conducting an in-human trial of its diagnostic patch.
It is now looking to expand into other regions such as the Middle East.
The startup has set up a subsidiary in New York using the proceeds from its first Series C round.
It plans to launch 100 more e-clinics in the next 12 months.
They will try out wearable technologies to improve health monitoring.
The new funds will go toward further scaling its platform in the United States.
It will be used to accelerate collaborations with pharmaceutical firms.
It will use its latest funds for its global expansion.
Also, CureApp is getting $77 million in investment from the Sawai Group as part of their license deal.
The new funds will be used to support the rollout of its hypertension DTx app.